The COVID-19 pandemic sparked national concern about vulnerabilities in the drug supply chain. Many drugs procured in the United States are manufactured abroad. The pandemic disrupted the production of key pharmaceutical ingredients around the world, sparking fear about resulting shortages of key medicines. The system also struggled to keep pace with rising demand for drugs to treat patients with COVID-19. During this webinar, panelists will explore the impact of the pandemic on different facets of the drug supply chain and discuss policy options to strengthen the system.
As a number of states begin to lift stay-at-home orders, questions remain around strategies to curb the continued spread of COVID-19. Public health officials are ramping up efforts to monitor and contain new cases through contact tracing, a disease control method used to identify and notify individuals who have been exposed to the virus. The strategy is a key component of other nations’ efforts to safely ease social distancing measures. During this webinar, panelists will discuss cases studies from abroad and best practices as policymakers look to implement a contact tracing strategy in the United States.
The webinar will review the key mindset, leadership, and design shifts leaders and organizations can make to create organizational capacity for both stability and responsiveness during times of unpredictability and disruption.
How is COVID-19 impacting physicians’ practices and what does that mean for your business? Join AbelsonTaylor and Veeva Systems for a webinar to explore findings from a survey of 500 physicians in 9 different specialties about the impact of COVID-19.
Virtual meetings are now an essential part of doing business for life science organizations. But your approach to virtual engagement and online collaboration will vary based on the phase of the pharmaceutical lifecycle development, participant type, and internal teams involved.
Dr. Brian Patel, Chief of Emergency Medicine at Sturdy Memorial Hospital, and Deborah Jean Parsons, Ph.D. Director of Integrated Care at Aspire Health Alliance, share actionable best practices for developing better community partnerships to support patients struggling with complex comorbid physical, behavioral, mental, and SDOH challenges.
As COVID-19 threatens the global supply chain, join FierceHealthcare and FiercePharma on March 30th through April 1st for a free virtual event on What’s Next.
Join Ipsos for an interactive, complimentary “Ask us anything” webinar examining how public mood is changing as a result of Covid-19, where concerns are most focused now, and how the crisis is affecting American’s behavior now and in the future.
Caring for patients with complex physical, behavioral, and mental health conditions requires a community effort—especially when those patients also face social determinants of health. Learn how communities are working together to achieve over 100% growth in patient engagement and a 78% reduction in ED utilization through care collaboration.
Join moderator Lynne Devlin, Registered Nurse and VP of Clinical Outreach Services, for a conversation with three people living with cancer about how the threat of COVID-19 is different for them.
